Scientists decode tumor DNA to sharpen cancer diagnosis

NCT ID NCT07268066

Recruiting now Knowledge-focused Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at DNA methylation patterns in brain, thyroid, and endometrial tumors. Researchers aim to better classify these cancers and find new markers for early diagnosis. The study will involve 180 participants and uses existing tumor samples.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to classify tumors and identify new targets for diagnosis or treatment.
What could go wrong: This is an observational study, not a treatment trial. It may not directly benefit participants and results may take years to apply in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer endometrial carcinoma glioma thyroid cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR CANCER

Contacts and locations

Locations

IRCCS Azienda Ospedaliero Univesitaria di Bologna
RECRUITING

Bologna, BO, 40138, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.